Clinical Trials for 19 and 22+ B Cell Hematologic Tumors

Find clinical trials for 19 and 22+ b cell hematologic tumors. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

To Observe the Dual-target Chimeric Antigen Receptor T Cells in the Treatment of B Cell Hematologic Tumors

NCT ID: NCT05388695

This clinical trial is studying a new treatment approach using a special type of immune cells called dual-target chimeric antigen receptor (CAR) T cells for patients with certain types of B cell bl...

Recruiting

Phase: PHASE1 Type: interventional Locations: Wuhan, Hubei, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions